-
2
-
-
33846226474
-
Factors influencing the colla-genase digestions phase of human islet isolation
-
Kin T, Johnson PRV, Shapiro AMJ, et al. Factors influencing the colla-genase digestions phase of human islet isolation. Transplantation 2007; 83: 7.
-
(2007)
Transplantation
, vol.83
, pp. 7
-
-
Kin, T.1
Johnson, P.R.V.2
Shapiro, A.M.J.3
-
3
-
-
0030988289
-
Improved human islet isolation using a new enzyme blend, liberase
-
Linetsky E, Bottino R, Lehmann R, et al. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997; 46: 1120.
-
(1997)
Diabetes
, vol.46
, pp. 1120
-
-
Linetsky, E.1
Bottino, R.2
Lehmann, R.3
-
4
-
-
0033377102
-
Improved method for the isolation and purification of human islets of langerhans using Liberase enzyme blend
-
Olack BJ, Swanson CJ, Howard TK, et al. Improved method for the isolation and purification of human islets of langerhans using Liberase enzyme blend. Hum Immunol 1999; 60: 1303.
-
(1999)
Hum Immunol
, vol.60
, pp. 1303
-
-
Olack, B.J.1
Swanson, C.J.2
Howard, T.K.3
-
5
-
-
26644449660
-
Quantitative assessment of colla-genase blends for human islet isolation
-
Barnett MJ, Zhai X, LeGatt DF, et al. Quantitative assessment of colla-genase blends for human islet isolation. Transplantation 2005; 80: 723.
-
(2005)
Transplantation
, vol.80
, pp. 723
-
-
Barnett, M.J.1
Zhai, X.2
Legatt, D.F.3
-
6
-
-
37349077889
-
Deterioration and variability of highly purified collagenase blends used in clinical islet isolation
-
Yamamoto T, Ricordi C, Messinger S, et al. Deterioration and variability of highly purified collagenase blends used in clinical islet isolation. Transplantation 2007; 84: 997.
-
(2007)
Transplantation
, vol.84
, pp. 997
-
-
Yamamoto, T.1
Ricordi, C.2
Messinger, S.3
-
7
-
-
77951294778
-
-
International Center for Cellular Therapy Accessed Augus 30 2009
-
International Center for Cellular Therapy. Risk of bovine spongiform encephalopathy (BSE) in collagenase enzymes. 2007. Available at: http://www.celltherapysociety.org/files/PDF/Resources/Risk-BSE-in- Collagenase-Enzymes.pdf. Accessed August 30 2009.
-
(2007)
Risk of Bovine Spongiform Encephalopathy (BSE) in Collagenase Enzymes.
-
-
-
8
-
-
19944434343
-
Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation
-
Bucher P, Mathe Z, Morel P, et al. Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 2005; 79: 91.
-
(2005)
Transplantation
, vol.79
, pp. 91
-
-
Bucher, P.1
Mathe, Z.2
Morel, P.3
-
9
-
-
61849174264
-
The importance of tryptic-like activity in purified enzyme blends for efficient islet isolation
-
Brandhorst H, Friberg A, Andersson HH, et al. The importance of tryptic-like activity in purified enzyme blends for efficient islet isolation. Transplantation 2009; 87: 370.
-
(2009)
Transplantation
, vol.87
, pp. 370
-
-
Brandhorst, H.1
Friberg, A.2
Andersson, H.H.3
-
10
-
-
67649607437
-
Nonsimultaneous administration of pancreas dissociation enzymes during islet isolation
-
Kin T, O'Gorman D, Zhai X, et al. Nonsimultaneous administration of pancreas dissociation enzymes during islet isolation. Transplantation 2009; 87: 1700.
-
(2009)
Transplantation
, vol.87
, pp. 1700
-
-
Kin, T.1
O'Gorman, D.2
Zhai, X.3
-
11
-
-
34247359167
-
Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme
-
Kin T, Zhai X, Murdoch TB, et al. Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant 2007; 7: 1233.
-
(2007)
Am J Transplant
, vol.7
, pp. 1233
-
-
Kin, T.1
Zhai, X.2
Murdoch, T.B.3
-
12
-
-
33646692209
-
Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes
-
Balamurugan AN, Bottino R, Giannoukakis N, et al. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas 2006; 32: 231.
-
(2006)
Pancreas
, vol.32
, pp. 231
-
-
Balamurugan, A.N.1
Bottino, R.2
Giannoukakis, N.3
-
13
-
-
36248993018
-
Improved human pancreatic islet purification with the refined UIC-UB density gradient
-
Barbaro B, Salehi P, Wang Y, et al. Improved human pancreatic islet purification with the refined UIC-UB density gradient.Transplantation 2007; 84: 1200.
-
(2007)
Transplantation
, vol.84
, pp. 1200
-
-
Barbaro, B.1
Salehi, P.2
Wang, Y.3
-
14
-
-
40949127890
-
Factors that affect human islet isolation
-
Sakuma Y, Ricordi C, Miki A, et al. Factors that affect human islet isolation. Transplant Proc 2008; 40: 343.
-
(2008)
Transplant Proc
, vol.40
, pp. 343
-
-
Sakuma, Y.1
Ricordi, C.2
Miki, A.3
-
15
-
-
40949096525
-
Development and characterization of a collagen degradation assay to assess purified collagenase used in islet isolation
-
McCarthy RC, Spurlin B, Wright MJ, et al. Development and characterization of a collagen degradation assay to assess purified collagenase used in islet isolation. Transplant Proc 2008; 40: 339.
-
(2008)
Transplant Proc
, vol.40
, pp. 339
-
-
McCarthy, R.C.1
Spurlin, B.2
Wright, M.J.3
-
16
-
-
0023491840
-
Utilization of FPLC-purified bacterial collagenase for the isolation of cells from bone
-
Hefley TJ. Utilization of FPLC-purified bacterial collagenase for the isolation of cells from bone. J Bone Miner Res 1987; 2: 505.
-
(1987)
J Bone Miner Res
, vol.2
, pp. 505
-
-
Hefley, T.J.1
-
18
-
-
13844265752
-
Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes
-
Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
-
(2005)
JAMA
, vol.293
, pp. 830
-
-
Hering, B.J.1
Kandaswamy, R.2
Ansite, J.D.3
-
19
-
-
0024532672
-
Automated islet isolation from human pancreas
-
Ricordi C,Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989; 38(suppl 1): 140.
-
(1989)
Diabetes
, vol.38
, Issue.SUPPL. 1
, pp. 140
-
-
Ricordi Clacy, P.E.1
Scharp, D.W.2
-
20
-
-
33644793661
-
Harmful delayed effects of exogenous isolation enzymes on isolated human islets: Relevance to clinical transplantation
-
Balamurugan AN, He J, Guo FL, et al. Harmful delayed effects of exogenous isolation enzymes on isolated human islets: Relevance to clinical transplantation. Am J Transplant 2005; 5: 2671.
-
(2005)
Am J Transplant
, vol.5
, pp. 2671
-
-
Balamurugan, A.N.1
He, J.2
Guo, F.L.3
-
21
-
-
33847704983
-
Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice
-
Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant 2007; 7: 707.
-
(2007)
Am J Transplant
, vol.7
, pp. 707
-
-
Papas, K.K.1
Colton, C.K.2
Nelson, R.A.3
-
22
-
-
0029619468
-
Human pancreatic dissociation using a purified enzyme blend
-
Fetterhoff TJ, Cavanagh TJ, Wile KJ, et al. Human pancreatic dissociation using a purified enzyme blend. Transplant Proc 1995; 27: 3282.
-
(1995)
Transplant Proc
, vol.27
, pp. 3282
-
-
Fetterhoff, T.J.1
Cavanagh, T.J.2
Wile, K.J.3
-
23
-
-
0032532618
-
A Simplified endoproteinase assays using gelatin or azogelatin
-
Jones BL, Fontanini D, Jarvinen M, et al. A. Simplified endoproteinase assays using gelatin or azogelatin. Anal Biochem 1988; 263: 214.
-
(1988)
Anal Biochem
, vol.263
, pp. 214
-
-
Jones, B.L.1
Fontanini, D.2
Jarvinen, M.3
-
24
-
-
0032891451
-
Gene duplication and multiplicity of collagenases in Clostridium histolyticum
-
Matsushita O, Jung CM, Katayama S, et al. Gene duplication and multiplicity of collagenases in Clostridium histolyticum. J Bacteriol 1999; 181: 923.
-
(1999)
J Bacteriol
, vol.181
, pp. 923
-
-
Matsushita, O.1
Jung, C.M.2
Katayama, S.3
-
25
-
-
0028952452
-
Different roles of class i and class II Clostridium histolyticum collagenase in rat pancreatic islet isolation
-
Wolters GH, Vos-Scheperkeuter GH, Lin HC, et al. Different roles of class I and class II Clostridium histolyticum collagenase in rat pancreatic islet isolation. Diabetes 1995; 44: 227.
-
(1995)
Diabetes
, vol.44
, pp. 227
-
-
Wolters, G.H.1
Vos-Scheperkeuter, G.H.2
Lin, H.C.3
-
26
-
-
40049107303
-
The ratio between collagenase class i and class II influences the efficient islet release from the rat pancreas
-
Brandhorst H, Raemsch-Guenther N, Raemsch R. The ratio between collagenase class I and class II influences the efficient islet release from the rat pancreas. Transplantation 2008; 85: 456.
-
(2008)
Transplantation
, vol.85
, pp. 456
-
-
Brandhorst, H.1
Raemsch-Guenther, N.2
Raemsch, R.3
-
27
-
-
53749098939
-
Detrimental effect of excessive col-lagenase class IIonhuman islet isolation outcome
-
Kin T, Zhai X, O'Gorman D, et al. Detrimental effect of excessive col-lagenase class IIonhuman islet isolation outcome. Transpl Int 2008; 21: 1059.
-
(2008)
Transpl Int
, vol.21
, pp. 1059
-
-
Kin, T.1
Zhai, X.2
O'Gorman, D.3
-
28
-
-
77951298171
-
TM collagenase blends
-
Accessed August 30 2009
-
TM collagenase blends. Islet Cell Resource Center Workshop 2005. Available at: http://icr.coh.org/docs/PDF%20Powerpoint% 20Conversions/Lakey%20Collagenase%20Slides.pdf. Accessed August 30, 2009.
-
(2005)
Islet Cell Resource Center Workshop
-
-
Lakey, J.R.T.1
-
29
-
-
0024494322
-
Protease activity in pancreatic islet isolation by enzymatic digestion
-
McShane P, Sutton R, Gray DW, et al. Protease activity in pancreatic islet isolation by enzymatic digestion. Diabetes 1989; 38(suppl 1): 126.
-
(1989)
Diabetes
, vol.38
, Issue.SUPPL. 1
, pp. 126
-
-
McShane, P.1
Sutton, R.2
Gray, D.W.3
-
30
-
-
0030764439
-
Histo-chemical analysis of the role of class i and class II Clostridium histolyticum collagenase in the degradation of rat pancreatic extracellular matrix for islet isolation
-
Vos-Scheperkeuter GH, Van Suylichem PTR, Vonk MW, et al. Histo-chemical analysis of the role of class I and class II Clostridium histolyticum collagenase in the degradation of rat pancreatic extracellular matrix for islet isolation. Cell Transplant 1997; 6: 403.
-
(1997)
Cell Transplant
, vol.6
, pp. 403
-
-
Vos-Scheperkeuter, G.H.1
Van Suylichem, P.T.R.2
Vonk, M.W.3
-
31
-
-
84960804081
-
-
Food and Drug Administration Accessed August 30 2009
-
Food and Drug Administration. Guidance for Industry: Considerations for allogenic pancreatic islet cell products. 2008. Available at: http://www. fda.gov/downloads/BiologicsBloodVaccines/GuidanceCompliance RegulatoryInformation/Guidances/CellularandGeneTherapy/UCM166165. pdf. Accessed August 30, 2009.
-
(2008)
Guidance for Industry: Considerations for Allogenic Pancreatic Islet Cell Products.
-
-
|